SCHEMBL3632065

SCHEMBL3632065

Cc1ccccc1Pc1ccccc1-c1ccccc1Pc1ccccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
ALDH1A1 P00352 3/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA7 P43166 1/20 0.35
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MYC P01106 1/20 0.32
GAA P10253 1/20 0.32
IDO1 P14902 1/20 0.32
METAP2 P50579 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146928 0.89 TSHR (0.53) ACHETSHRALDH1A1CA1CA2
Hydrochloric Acid SCHEMBL541709 0.87 TSHR (0.50) ACHETSHRALDH1A1CA1CA2
SCHEMBL29083664 0.87 TSHR (0.50) ACHETSHRALDH1A1CA1CA2
SCHEMBL1304780 0.87 TSHR (0.50) ACHETSHRALDH1A1CA1CA2
SCHEMBL5645150 0.87 TSHR (0.50) ACHETSHRALDH1A1CA1CA2
SCHEMBL31457202 0.87 TSHR (0.50) ACHETSHRALDH1A1CA1CA2
SCHEMBL5138180 0.87 CYP2A6 (0.41) ACHETSHRNPC1RAB9ASMN1; SMN2
SCHEMBL14604156 0.84 APP (0.43) SMN1; SMN2ALDH1A1CA1CA2CA9
Hydrochloric Acid SCHEMBL3223494 0.84 TSHR (0.47) ACHETSHRALDH1A1CA1CA2
Hydrochloric Acid SCHEMBL29042332 0.84 TSHR (0.47) ACHETSHRALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754924-B2 Process for the monosulfonation of aromatic phosphines, and zwitterionic product derived therefrom DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-13 US disclosed
US-20080221363-A1 Process for the Monosulfonation of Aromatic Phosphines, and Zwitterionic Product Derived Therefrom DOW GLOBAL TECHNOLOGIES INC. (US) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221363-A1 Process for the Monosulfonation of Aromatic Phosphines, and Zwitterionic Product Derived Therefrom ITK, WEE1, WASF2 ACHE 3112/4885TSHR 3802/4885NPC1 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.